Abstract:Significance: Hypertrophic scarring is a challenging issue for patients and clinicians. The prevalence of hypertrophic scarring can be up to 70% after burns, and patients suffer from pain, itching, and loss of joint mobility. To date, the exact mechanisms underlying hypertrophic scar formation are unclear, and clinical options remain limited. Recent Advances: Several studies have demonstrated that pathological scars are a type of hyperactive vascular response to wounding. Scar regression has been found to be accompanied by microvessel occlusion, which causes severe hypoxia, malnutrition, and endothelial dysfunction, suggesting the essential roles of microvessels in scar regression. Therefore, interventions that target the vasculature, such as intense pulsed light, pulsed dye lasers, vascular endothelial growth factor antibodies, and Endostar, represent potential treatments. In addition, the mass of scar-associated collagen is usually not considered by current treatments. However, collagen-targeted therapies such as fractional CO2 laser and collagenase have shown promising outcomes in scar treatment. Critical Issues: Traditional modalities used in current clinical practice only partially target scar-associated microvessels or collagen. As a result, the effectiveness of current treatments is limited and is too often accompanied by undesirable side effects. The formation of scars in the early stage is mainly affected by microvessels, whereas the scars in later stages are mostly composed of residual collagen. Traditional therapies do not utilize specific targets for scars at different stages. Therefore, more precise treatment strategies are needed. Future Directions: Scars should be classified as either "vascular-dominant" or "collagen-dominant" before selecting a treatment. In this way, strategies that are vascular-targeted, collagen-targeted, or a combination thereof could be recommended to treat scars at different stages.

Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis

The Vascular Involvement in Soft Tissue Fibrosis—Lessons Learned from Pathological Scarring

Mechanotransduction in skin wound healing and scar formation: Potential therapeutic targets for controlling hypertrophic scarring.

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.

Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis

Toward understanding scarless skin wound healing and pathological scarring

Inflammation in Wound Healing and Pathological Scarring

Uncovering the nanoscale structure and biophysics of cutaneous fibrosis-A short review

An Update on Molecular Mechanisms of Scarring—A Narrative Review

Systemic factors that shape cutaneous pathological scarring

Hypertrophic Scar Regression is Linked to the Occurrence of Endothelial Dysfunction.

Epithelial–mesenchymal transition in the formation of hypertrophic scars and keloids

Scarring Skin: Mechanisms and Therapies

Mechanisms and Therapies

Vascular and Collagen Target: A Rational Approach to Hypertrophic Scar Management

Advances of Nanobiomaterials for Treating Skin Pathological Fibrosis

Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring.

Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis

The Pathophysiology and Management of Pathologic Scarring-a Contemporary Review

Biomaterial-based mechanical regulation facilitates scarless wound healing with functional skin appendage regeneration